Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Epizyme Inc (EPZM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2021	12-2020	09-2020	06-2020	03-2020
Assets
Current Assets
Cash & Cash Equivalents	73,711	168,215	93,422	117,152	179,262
Marketable Securities	225,232	205,391	186,485	204,910	197,199
Receivables	9,764	3,105	4,611	1,747	1,649
Inventories	14,817	10,461	8,157	9,864	1,703
TOTAL	$340,417	$405,093	$311,185	$354,664	$402,440

Non-Current Assets
PPE Net	2,035	2,152	2,120	2,268	2,071
Intangibles	45,964	47,002	48,041	49,079	24,702
Other Non-Current Assets	18,295	19,326	20,410	21,372	22,424
TOTAL	$66,294	$68,480	$70,571	$72,719	$49,197

Total Assets	$406,711	$473,573	$381,756	$427,383	$451,637

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	5,357	10,163	7,370	4,583	5,928
Accrued Expenses	23,853	28,572	22,812	22,050	18,060
Other current liabilities	N/A	N/A	23	144	16
TOTAL	$39,006	$43,400	$34,780	$30,655	$27,183

Non-Current Liabilities
Long Term Debt	215,858	215,670	68,554	68,464	48,381
Deferred Revenues	5,000	N/A	N/A	N/A	N/A
Other Non-Current Liabilities	28,816	29,606	30,207	31,095	31,950
TOTAL	$244,674	$245,276	$102,567	$103,365	$84,137

Total Liabilities	$283,680	$288,676	$137,347	$134,020	$111,320

Shareholders' Equity
Shares Outstanding, K	101,976	101,785	101,581	101,478	101,061
Common Shares	10	10	10	10	10
Retained earnings	-1,058,987	-988,713	-922,480	-866,407	-807,956
Other shareholders' equity	6	3	120	460	-75
TOTAL	$123,031	$184,897	$244,409	$293,363	$340,317

Total Liabilities And Equity	$406,711	$473,573	$381,756	$427,383	$451,637